FMC CORP (FMC) Stock

MaterialsAgricultural Inputs Website

FMC has an Alpha Score of 31 out of 100 (poor), computed on Nov 1, 2026 from 4 of 4 sub-scores. 3 members of Congress disclosed 9 trades in FMC since 2020: 5 purchases and 4 sales, most recently Dan Newhouse (sale, Jul 10, 2026). 6 of the hedge funds AlphaScala tracks reported FMC in 13F filings for the quarter ended Jun 30, 2026; the largest reported position is D.E. Shaw's at $56.46M. Company insiders reported 0 open-market buys and 1 sale on SEC Form 4 in the 90 days to Nov 3, 2026.

$6.42
+5.42%
Last price
Source: Finnhub
Alpha Score
31
Poor

What is FMC's Alpha Score?

How it works →

Alpha Score of 31 reflects weak overall profile with poor momentum, strong value, poor quality, moderate sentiment.

Momentum
0
Poor
Value
77
Strong
Quality
6
Poor
Sentiment
50
Weak

Computed Nov 1, 2026

A rules-based research rating, not a recommendation to buy or sell.

Which members of Congress traded FMC CORP (FMC)?

Members
3
Disclosed trades
9
Purchases
5
Sales
4

Most recent: Dan Newhouse (sale, Jul 10, 2026); records start Apr 27, 2020.

PoliticianTrade dateTypeAmount
Dan Newhouse
R-WA · House
2026-07-10sale$1k – $15k
Lisa McClain
R-MI · House
2025-10-31sale$1k – $15k
Lisa McClain
R-MI · House
2025-10-30sale$1k – $15k
Lisa McClain
R-MI · House
2025-10-30purchase$1k – $15k
Lisa McClain
R-MI · House
2025-09-25purchase$1k – $15k
Dan Newhouse
R-WA · House
2024-04-10purchase$1k – $15k
Susie Lee
D-NV · House
2021-05-26sale$1k – $15k
Susie Lee
D-NV · House
2020-08-27purchase$1k – $15k

From STOCK Act periodic transaction reports. House filings as of Nov 2, 2026.

See all FMC political trades →

Which hedge funds own FMC?

From 13F filings
FundShares HeldPosition ValueChange vs prior Q
D.E. Shaw
David Shaw
4.91M$56.46M-18%
Marshall Wace1.89M$21.70M+172%
Millennium Management
Israel Englander
1.09M$12.59M-2%
Point72
Steve Cohen
637K$7.33M+54%
Citadel
Ken Griffin
515K$5.93M+353%
Bridgewater Associates
Ray Dalio
66K$759.2K-38%

13F holdings as of Jun 30, 2026

Explore all tracked funds →

Are FMC CORP insiders buying or selling?

SEC Form 4 filings
90 days to Nov 3, 2026
Buys
0
Sells
1
Net $
-$16K
Unique insiders
1
DateInsiderRoleTypeSharesValue
Sep 9, 26Pfeiffer NicholasCorporate ControllerSELL1.3K$16K

SEC Form 4 filings as of Nov 3, 2026

See cluster-buy signals across all tickers →

What are FMC's key statistics?

EPS (TTM)
-22.02
Dividend Yield
4.37%
Beta
0.52
Net Margin
-84.83%
ROE
-118.57%
Debt / Equity
1.97
52W High
$22.00
52W Low
$4.37

Key statistics as of Nov 1, 2026

How does FMC's valuation compare with the Materials sector?

MetricFMCMaterials medianCompanies in median
Net margin-84.83%8.63%80
Return on equity-118.57%12.49%83
Dividend yield (payers)4.37%1.83%62

Medians over the Materials stocks whose key statistics were refreshed in the last 35 days (newest Nov 4, 2026). P/E excludes loss-making companies.

FMC price chart

Powered by TradingView

What does FMC CORP do?

FMC Corporation is an agricultural sciences company that develops and provides crop protection solutions to farmers worldwide. It specializes in insecticides under brands like Rynaxypyr, Cyazypyr, Talstar, and Hero; herbicides such as Authority, Boral, Centium, Command, and Gamit; flutriafol-based fungicides; and bionematicides including Quartzo and Presence. The company offers advanced farming technologies, including precision technologies, biological solutions, and synthetic and biobased agrochemical products to enhance crop productivity and resilience. FMC Corporation also serves non-crop segments like lawn care, golf courses, vegetation management, nursery, and ornamental applications. Its products address pest control, plant health, and turf management needs across diverse geographies, with operations in over 50 countries spanning North America, Latin America, Europe, Asia, the Middle East, and Africa. Founded in 1883 and headquartered in Philadelphia, Pennsylvania, FMC Corporation plays a key role in the global agrochemical market by supporting sustainable agriculture through its innovative portfolio.

CEO
Dr. Pierre R. Brondeau Ph.D.
Employees
5,500
Market Cap
$964.39M
Ask about FMCAI research agent